🔗 Visit the ClinicalTrials.gov page for NCT00254267
| Rank | Title | Journal | Year | PubWeight™‹?› |
|---|---|---|---|---|
| 1 | Efficacy and safety of motesanib, an oral inhibitor of VEGF, PDGF, and Kit receptors, in patients with imatinib-resistant gastrointestinal stromal tumors. | Cancer Chemother Pharmacol | 2010 | 0.92 |